Increased serum matrix metalloproteinase-1 concentration predicts advanced left ventricular remodeling in patients with acute myocardial infarction

Circulation Journal

Volumn 67, Issue 4, 2003, Pages 301-304

  Soejima, Hirofumi ^a   Ogawa, Hisao ^a   Sakamoto, Tomohiro ^a   Miyamoto, Shinzo ^a   Kajiwara, Ichiro ^a   Kojima, Sunao ^a   Hokamaki, Jun ^a   Sugiyama, Seigo ^a   Yoshimura, Michihiro ^a   Suefuji, Hisakazu ^b   Miyao, Yuji ^b   Fujimoto, Kazuteru ^b   Miyagi, Hiroo ^b   Kishikawa, Hideki ^c  

^a KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION KUMAMOTO MEDICAL CENTER   (Japan)

^c KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Metalloproteinase; Myocardial infarction; Remodeling

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; INTERSTITIAL COLLAGENASE; LONG ACTING DRUG; NITRATE;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BLOOD SAMPLING; CALCULATION; CLINICAL ARTICLE; COLLAGEN DEGRADATION; CORRELATION ANALYSIS; ENZYME BLOOD LEVEL; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE REMODELING; HEART VENTRICULOGRAPHY; HUMAN; MALE; PREDICTION; PROGNOSIS;

EID: 0037389995     PISSN: 13469843     EISSN: None     Source Type: Journal    
DOI: 10.1253/circj.67.301     Document Type: Article

References (18)

1. Etoh T, Joffs C, Deschamps AM, Davis J, Dowdy K, Hendrick J, et al. Myocardial and interstitial matrix metalloproteinase activity after acute myocardial infarction in pigs. Am J Physiol Heart Circ Physiol 2001; 281: H987-H994.
2. Podesser BK, Siwik DA, Eberli FR, Sam F, Ngoy S, Lambert J, et al. ET(a)-receptor blockade prevents matrix metalloproteinase activation late postmyocardial infarction in the rat. Am J Physiol Heart Circ Physiol 2001; 280: H984-H991.
3. Tyagi SC, Campell SE, Reddy HK, Tjaha E, Voelker DJ. Matrix metalloproteinase activity expression in infarcted, noninfarcted and dilated cardiomyopathic human hearts. Mol Cell Biochem 1996; 155: 13-21.
4. Meizlish JL, Berger RE, Olankey M, Erricao D, Levy W, Zaret BL. Functional left ventricular aneurysm formation after acute anterior transmural myocardial infarction: Incidence, natural history, and prognostic implications. N Engl J Med 1984; 311: 1001-1006.
5. Morris KG, Palmeri ST, Califf RM, McKinnis RA, Higginbothan MB, Coleman RE. Value of radionuclide angiography for predicting specific cardiac events after acute myocardial infarction. Am J Cardiol 1985; 55: 318-324.
6. Sakuma T, Okada T, Hayashi Y, Otsuka M, Hirai Y. Optimal time for predicting left ventricular remodeling after successful primary coronary angioplasty in acute myocardial infarction using serial myocardial contrast echocardiography and magnetic resonance imaging. Circ J 2002; 66: 685-690.
7. Zhang J, Fujimoto N, Iwata K, Sakai T, Okada Y, Hayakawa T. A one-step sandwich enzyme immunoassay for human matrix metalloproteinase1 (interstitial collagenase) using monoclonal antibodies. Clin Chim Acta 1993; 221: 91-103.
8. Wallenstein S, Zucker CL, Fleiss JL. Some statistical methods useful in circulation research. Circ Res 1980; 47: 1-9.
9. Kai H, Ikeda H, Yasukawa H, Kai M, Seki Y, Kuwahara F, et al. Peripheral blood levels of matrix metalloproteases-2 and -9 are elevated in patients with acute coronary syndromes. J Am Coll Cardiol 1998; 32: 368-372.
10. Inokubo Y, Hanada H, Ishizaka H, Fukushi T, Kamada T, Okumura K. Plasma levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 are increased in the coronary circulation in patients with acute coronary syndrome. Am Heart J 2001; 141: 211-217.
11. Hirohata S, Kusachi S, Murakami M, Murakami T, Sano I, Watanabe T, et al. Time dependent alterations of serum matrix metalloproteinase-1 and metalloproteinase-1 tissue inhibitor after successful reperfusion of acute myocardial infarction. Heart 1997; 78: 278-284.
12. Cleutjens JP, Kandala JC, Guarda E, Guntaka RV, Weber KT. Regulation of collagen degradation in the rat myocardium after infarction. J Mol Cell Cardiol 1995; 27: 1281-1292.
13. Hojo Y, Ikeda U, Ueno S, Arakawa H, Shimada K. Expression of matrix metalloproteinases in patients with acute myocardial infarction. Jpn Circ J 2001; 65: 71-75.
14. Lefebvre V, Peeters-Joris C, Vaes G. Modulation by interleukin-1 and tumor necrosis factor of production of collagenase, tissue inhibitor of metalloproteinases and collagen types in differentiated and dedifferentiated articular chondrocytes. Biochim Biophys Acta 1990; 1052: 366-378.
15. Manicourt DH, Fujimoto N, Obata K, Tronar EJ. Levels of circulating collagenase, stromelysin-1 and tissue inhibitor of matrix metalloproteinase 1 in patients rheumatoid arthritis: Relationship to serum levels of antigenic keratan sulfate and systemic parameters of inflamation. Arthritis Rheum 1995; 38: 1031-1039.
16. Herskowitz A, Choi S, Ansai AA, Wesselingh S. Cytokine mRNA expression in postischemic/reperfused myocardium. Am J Pathol 1995; 146: 419-428.
17. Yokoseki O, Yazaki Y, Suzuki J, Imamura H, Takenaka H, Isobe M. Association of matrix metalloproteinase expression and left ventricular function in idiopathic dilated cardiomyopathy. Jpn Circ J 2000; 64: 352-357.
18. Rohde LE, Ducharme A, Arroyo LH, Aikawa M, Sukhova GH, Lopez-Anaya A, et al. Matrix metalloproteinase inhibition attenuates early left ventricular enlargement after experimental myocardial infarction in mice. Circulation 1999; 99: 3063-3070.